XOMA Corporation (Nasdaq: XOMA) announced that its study of XMetA, the company’s fully-human allosteric monoclonal antibody to the insulin receptor, is available online and will be published in the May issue of the American Diabetes Association’s journal Diabetes.
Read more
First allosteric insulin receptor-activating antibody to improve glycemic control in vivo
March 8, 2012 |
Permalink
Warning: Trying to access array offset on value of type bool in /var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php on line 20
Tweet
Warning: Trying to access array offset on value of type bool in /var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php on line 20
Tweet
Posted in Drugs